Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: NOMOCAN PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-02-27 to 2024-11-26
Current total value of award: $354959
Description: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE END DATE FROM FEBRUARY 26, 2024 TO NOVEMBER 26, 2024.  AS A RESULT, ARTICLES C.1, F.1., G.3 AND SECTION J ARE UPDATED